跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOVOTHIRTEEN catridecacog (rys) 2500 IU powder for injection vial with diluent vial - TGA Drug Approval Details
Approvals
/
TGA
/
NOVOTHIRTEEN catridecacog (rys) 2500 IU powder for injection vial with diluent vial
Approved
STANDARD
NOVOTHIRTEEN catridecacog (rys) 2500 IU powder for injection vial with diluent vial
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a0e3f6a5bed41d2f
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
a0e3f6a5bed41d2f
Product Name
NOVOTHIRTEEN catridecacog (rys) 2500 IU powder for injection vial with diluent vial
Artg Id
201776
Artg Name
NOVOTHIRTEEN catridecacog (rys) 2500 IU powder for injection vial with diluent vial
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2013-11-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/217fccd764a4f398395087391e50c494.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/da80fb8a2df9edd1e265eb83c995f078.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a0e3f6a5bed41d2f
Type
Standard
Back to TGA Approvals